What Is PQQ? The Brain Energy Nutrient Women Over 40 Should Know About

What Is PQQ and Does It Support Brain and Energy Health After 40?

Among the emerging nootropic and longevity supplements, PQQ (pyrroloquinoline quinone) is one that earns attention for a specific reason: it is the only known nutritional compound that stimulates the creation of new mitochondria rather than just supporting existing ones. Given that mitochondrial decline is a central mechanism of the energy and cognitive changes women experience after 40, this particular mechanism makes PQQ worth understanding. The science is still developing compared to more established compounds, but what exists is compelling enough to merit a clear-eyed assessment.

What PQQ Is: The Chemistry Behind the Compound

PQQ is a quinone compound originally discovered as a cofactor for bacterial dehydrogenase enzymes. In mammals, PQQ is not synthesized endogenously and must be obtained from diet, placing it in the category of nutritionally important compounds that function similarly to vitamins without meeting the strict definition. It was once proposed to be designated Vitamin B14, though this classification was not formally adopted.

PQQ’s chemical structure includes a tricyclic quinone ring system that allows it to cycle repeatedly between oxidized and reduced states without being destroyed in the process. This cycling capacity is what makes it an extraordinarily potent antioxidant: where vitamin C can donate electrons to neutralize free radicals approximately 4 times before being depleted, PQQ can cycle approximately 20,000 times before degradation. This makes PQQ one of the most efficient antioxidants available, particularly relevant in mitochondria where reactive oxygen species are continuously generated as a byproduct of energy production.

The Mitochondrial Biogenesis Mechanism: Why PQQ Is Unique

The defining property that distinguishes PQQ from most other mitochondria-supportive compounds is its activation of PGC-1 alpha (peroxisome proliferator-activated receptor gamma coactivator 1 alpha). PGC-1 alpha is the master transcription coactivator that controls the expression of genes required to create new mitochondria, including nuclear respiratory factors (NRF1, NRF2) and mitochondrial transcription factor A (TFAM). When PGC-1 alpha is activated, cells respond by building new mitochondrial membranes, replicating mitochondrial DNA, and assembling new electron transport chain complexes.

This distinction matters enormously for aging biology. After 40, mitochondrial number and quality decline through accumulated oxidative damage, reduced mitochondrial biogenesis activity, and the progressive deletion of mitochondrial DNA in tissues that experience high oxidative stress. CoQ10, NAD+, and other mitochondrial supplements support the function of existing mitochondria. PQQ, through PGC-1 alpha activation, is the only known nutritional compound that prompts cells to build new mitochondria, addressing the decline in mitochondrial mass rather than just optimizing what remains.

Animal studies published in the Journal of Nutritional Biochemistry found that dietary PQQ deprivation in mice caused significant reductions in mitochondrial content and function, while PQQ supplementation in aged animals increased mitochondrial mass and improved mitochondrial respiration efficiency. These effects were mediated through the PGC-1 alpha pathway and were associated with improvements in energy expenditure and physical performance.

PQQ and Brain Health: The Nerve Growth Factor Connection

Beyond mitochondria, PQQ has a specific neuroprotective mechanism that makes it particularly relevant for cognitive health after 40. PQQ stimulates the synthesis and release of nerve growth factor (NGF), the protein that supports the survival, maintenance, and growth of neurons, particularly the cholinergic neurons of the basal forebrain that are critical for memory and attention. These are the same neurons that decline in Alzheimer’s disease, and they are also the neurons most sensitive to the estrogen decline of perimenopause.

PQQ’s NGF stimulation works through a different pathway than lion’s mane mushroom (which also stimulates NGF through hericenones and erinacines). This makes them potentially synergistic: PQQ and lion’s mane activate NGF through different molecular triggers, and combining them may provide broader neurotrophin support than either alone. Given that both compounds also support mitochondrial function in neurons (brain cells have among the highest mitochondrial density of any tissue and are especially vulnerable to bioenergetic decline), the combination is gaining attention from neuroscientists focused on preventive cognitive health.

What Human Clinical Trials Show

Human clinical evidence for PQQ is more limited than for established nootropics, but the available data is encouraging. A 2009 randomized trial published in Functional Foods in Health and Disease gave Japanese adults PQQ (20 mg daily) or placebo for 8 weeks and found significant improvements in composite cognitive test scores, particularly in memory and attention domains, compared to placebo. A 2016 study combining PQQ (20 mg) and CoQ10 (300 mg) found significantly greater improvements in cognitive performance and fatigue measures than PQQ alone, supporting the synergistic combination.

A 2012 placebo-controlled trial in Functional Foods in Health and Disease assessed the effects of PQQ on sleep quality and fatigue in middle-aged adults. PQQ supplementation (20 mg daily for 8 weeks) significantly improved sleep quality scores (Pittsburgh Sleep Quality Index), reduced fatigue (as measured by Profile of Mood States), and improved vigorousness compared to placebo. For perimenopausal women dealing with sleep disruption and daytime fatigue, these are directly relevant outcomes.

PQQ and CoQ10: A Synergistic Pair

The combination of PQQ and CoQ10 is probably the most practically useful way to use PQQ for women over 40. CoQ10 serves as an electron carrier within the mitochondrial electron transport chain of existing mitochondria, supporting ATP output from the mitochondria already present in cells. PQQ, through PGC-1 alpha, stimulates the creation of new mitochondria. Together, they address two different dimensions of the mitochondrial decline that drives aging-related fatigue and cognitive slowdown: CoQ10 optimizes current mitochondrial function while PQQ drives regeneration of mitochondrial mass.

The 2016 clinical trial cited above found that the PQQ-CoQ10 combination outperformed PQQ alone for cognitive and fatigue outcomes, consistent with this mechanistic rationale. For practical use: take PQQ (10-20 mg) alongside CoQ10 (100-200 mg ubiquinol) with a fat-containing meal for best absorption. Both are fat-soluble compounds and absorb significantly better with dietary fat. Morning is the preferred timing for energy-supporting supplements, aligning supplementation with the body’s peak energy demand period.

Food Sources and Supplemental Dosing

PQQ is found in small amounts in several foods: natto (fermented soybeans) at 61 ng/g, green peppers at 28 ng/g, parsley at 17 ng/g, and kiwi fruit at 27 ng/g. These amounts are in nanograms: the clinical trial doses of 10-20 mg are roughly 1000 times higher than typical dietary intake. Even a very PQQ-rich diet provides only about 1-2 mcg (0.001-0.002 mg) per day, making supplementation the only way to achieve the research-supported doses.

Supplemental doses used in clinical research range from 10-20 mg daily. Most practitioners recommend starting at 10 mg and assessing response before increasing to 20 mg. PQQ is well tolerated: no significant side effects have been reported in human trials at standard doses. It is generally considered safe and is widely available as a dietary supplement. Some women find taking it in the morning reduces any potential sleep-adjacent effects, though unlike stimulants, PQQ has shown improved (not worsened) sleep quality in trials.

Frequently Asked Questions

What makes PQQ different from other antioxidants?

Most antioxidants (including vitamin C and vitamin E) are consumed in the process of neutralizing free radicals, meaning they can only perform this function a limited number of times. PQQ can cycle between oxidized and reduced states approximately 20,000 times before degradation, making it one of the most catalytically efficient antioxidants known. This cycling capacity is particularly valuable in mitochondria, where free radicals are generated continuously during energy production.

How long does PQQ take to show results?

The clinical trials showing cognitive and fatigue benefits used PQQ for 8 weeks. Most women who respond well report noticeable improvements in mental clarity and reduced afternoon fatigue within 4-6 weeks. Mitochondrial biogenesis effects (creating new mitochondria) are a longer-term process that builds over months of consistent supplementation rather than producing immediate effects.

Is PQQ safe for long-term use?

Human clinical trials of up to 8 weeks show excellent tolerability. The compound occurs naturally in breast milk and food, and no toxicity has been identified at supplemental doses of 10-20 mg daily. Longer-term safety studies are not yet available, but existing evidence is reassuring. As with any supplement, discussing with your healthcare provider if you have specific health conditions is advisable.

Can PQQ help with perimenopause brain fog specifically?

Directly for brain fog, PQQ addresses two relevant mechanisms: mitochondrial energy deficit in neurons (which contributes to the “flat” cognitive performance common in perimenopause) and NGF stimulation for cholinergic neuron maintenance. The combination with CoQ10 appears to amplify the cognitive benefits. While human trials specifically in perimenopausal women are not yet available, the mechanisms are highly relevant to this population.

What is the difference between PQQ and ubiquinol (CoQ10)?

CoQ10 (ubiquinol is the reduced, active form) functions as an electron carrier within the mitochondrial respiratory chain, supporting ATP production in existing mitochondria. PQQ activates PGC-1 alpha to stimulate the creation of new mitochondria. They work at different stages of the mitochondrial lifecycle: CoQ10 optimizes current function, PQQ drives regeneration. Used together, they address both dimensions of mitochondrial health comprehensively.

PQQ in a Comprehensive Mitochondrial Protocol for Women Over 40

PQQ is most useful when positioned within a broader mitochondrial health strategy rather than used in isolation. Mitochondrial decline after 40 operates across multiple dimensions simultaneously: reduced NAD+ availability limits electron transport chain function, CoQ10 decline reduces ATP output per mitochondrion, accumulated mitochondrial DNA mutations impair respiratory efficiency, and falling PGC-1 alpha activity reduces the rate at which new mitochondria are created to replace damaged ones. No single compound addresses all of these dimensions, but a targeted multi-compound approach can address each.

A practical mitochondrial protocol for women over 40 integrates NMN or NR (300-500 mg) to restore NAD+ levels and support SIRT1 and SIRT3 deacetylase activity, CoQ10 as ubiquinol (100-200 mg) to support electron carrier function within existing mitochondria, and PQQ (10-20 mg) to activate PGC-1 alpha and stimulate mitochondrial biogenesis. This combination addresses substrate availability (NAD+), operational efficiency (CoQ10), and regenerative capacity (PQQ) as three complementary layers. Magnesium malate (supporting the citric acid cycle enzymes that feed electrons into NAD+) and alpha-lipoic acid (recycling antioxidants within mitochondria) round out the most evidence-supported elements of a comprehensive approach.

For women experiencing significant fatigue, reduced exercise capacity, or cognitive slowdown after 40, this mitochondria-focused protocol represents one of the most mechanistically coherent supplementation strategies available. PQQ’s contribution, the regeneration of mitochondrial mass rather than simply optimizing existing mitochondria, is the component most difficult to replicate through other means, and it is the reason PQQ occupies a distinct and non-redundant role in this protocol despite its smaller human evidence base relative to NMN or CoQ10.

References

1. Rucker R, et al. “Biochemical roles of pyrroloquinoline quinone (PQQ).” Journal of Nutrition. 2009;139(4):747-752. PMID: 19176747
2. Nakano M, et al. “Effects of pyrroloquinoline quinone disodium salt intake on cognitive function.” Functional Foods in Health and Disease. 2016;6(8):529-546.
3. Chowanadisai W, et al. “Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1 alpha expression.” Journal of Biological Chemistry. 2010;285(1):142-152. PMID: 19861415
4. Takatsu H, et al. “Pyrroloquinoline quinone protects cells against oxidative stress-induced cellular senescence.” Experimental Gerontology. 2012;47(6):432-439. PMID: 22481112
5. Harris CB, et al. “Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects.” Journal of Nutritional Biochemistry. 2013;24(12):2076-2084. PMID: 24231099

Written by the Happy Aging Team